Pathologic Validation of Deauville Score-Based Disease on F-18 FDG PET/CT after First-Line Treatment in Patients with Lymphoma-Reference-Cited by-同舟云学术

Pathologic Validation of Deauville Score-Based Disease on F-18 FDG PET/CT after First-Line Treatment in Patients with Lymphoma

Published:2024-06-15 Issue: Volume: Page:
ISSN:1869-3474
Container-title:Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Nucl Med Mol Imaging

Author:

Kumar Rajender,Krishnaraju Venkata Subramanian,Mittal Bhagwant Rai^ORCID,Shankar Kritin,Singh Harmandeep,Ramachandran Arivan,Bhattacharya Anish,Prakash Gaurav,Bal Amanjit,Malhotra Pankaj

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13139-024-00868-z.pdf

Reference28 articles.

1. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–58.2.

2. Metser U, Mohan R, Beckley V, Moshonov H, Hodgson D, Murphy G.. FDG PET/CT Response Assessment Criteria for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma at End of Therapy: A Multiparametric Approach. Nucl Med Mol Imaging. 2016;50:46–53.

3. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375 − 90.

4. Ben-Yehuda D, Polliack A, Okon E, Sherman Y, Fields S, Lebenshart P et al. Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. J Clin Oncol. 1996;14:2431-4.

5. Chatani S, Hasegawa T, Kato S, Murata S, Sato Y, Yamaura H, et al. Image-guided core needle biopsy in the diagnosis of malignant lymphoma: comparison with surgical excision biopsy. Eur J Radiol. 2020;127:108990.